Sohini Das In Kolkata

Stories by Sohini Das In Kolkata

Domestic sales a booster dose for pharma revenues

Domestic sales a booster dose for pharma revenues

Rediff.com   4 hours ago

Buoyant domestic sales are expected to lift revenues for pharma companies by 8-11 per cent in Q3FY26, even as declining generic Revlimid (cancer drug) sales in the US remain a key drag. Most brokerages forecast a modest 2-4 per cent growth in profit after tax (PAT) for the quarter. Hospitals and diagnostics companies, meanwhile, are likely to post much stronger numbers, with revenues seen growing 20-22 per cent year-on-year (Y-o-Y).

First-time luxury buyers power BMW to record sales

First-time luxury buyers power BMW to record sales

Rediff.com   4 hours ago

The share of first-time luxury customers in BMW's portfolio has risen sharply -- from around 43 per cent in 2024 to nearly 49 per cent in 2025. In some models, the figure is even higher.

Auto, ancillary sectors to see strong earnings momentum

Auto, ancillary sectors to see strong earnings momentum

Rediff.com   4 hours ago

The automobile and auto-ancillary sector is expected to show strong Q3FY26 results, aided by festival-led demand, rationalisation in goods and services tax (GST) rates for select categories of vehicles, easing interest rates, and improving rural sentiment.

Bajaj Chetak Takes the Slow Road To Global Reach

Bajaj Chetak Takes the Slow Road To Global Reach

Rediff.com   4 days ago

Bajaj Auto is planning a slow, calibrated push to take the Chetak, its electric scooter, to more than 100 countries on the strength of its distributor network and market-specific localisation rather than an aggressive global rollout, reports Sohini Das.

Mercedes-Benz Hits Speed Bump In 2025, Vows To Stay Course

Mercedes-Benz Hits Speed Bump In 2025, Vows To Stay Course

Rediff.com   4 days ago

Despite a 2.8 per cent fall in 2025 volumes, Mercedes-Benz India reported its best-ever revenue and profitability, led by top-end models, AMG growth and higher BEV mix.

Maruti Dzire is top-selling car of 2025!

Maruti Dzire is top-selling car of 2025!

Rediff.com   6 days ago

It is after seven years that a sedan has claimed the top spot -- Dzire had last achieved the No.1 position in 2018.

Healthcare IPOs See A Surge In 2025

Healthcare IPOs See A Surge In 2025

Rediff.com   8 Jan 2026

The surge has come alongside a decline in average issue sizes and more muted listing-day returns compared with last year.

Tata Motors leads EV pack in 2025, but pecking order could change

Tata Motors leads EV pack in 2025, but pecking order could change

Rediff.com   8 Jan 2026

Mahindra and Mahindra (M&M) recorded the sharpest acceleration among large players, with EV retail jumping to 33,513 units from 7,139 units, an almost 5-fold jump, aided by strong demand for new launches.

Simple Energy debuts Gen 2 e-scooters to drive 2026 growth

Simple Energy debuts Gen 2 e-scooters to drive 2026 growth

Rediff.com   6 Jan 2026

'This is not just a cosmetic refresh,' said Suhas Rajkumar, founder and chief executive officer of Simple Energy. 'We have re-engineered the battery integration, made the scooter lighter, improved performance and expanded the portfolio so customers can choose based on real usage needs.'

GST 2.0 boosts petrol-diesel car sales over EVs

GST 2.0 boosts petrol-diesel car sales over EVs

Rediff.com   10 Dec 2025

While GST on ICE vehicles was brought down significantly, for electric cars it remained at 5 per cent.

GST 2.0 Puts Luxury Cars In Fast Lane

GST 2.0 Puts Luxury Cars In Fast Lane

Rediff.com   10 Dec 2025

India's luxury auto market is rebounding after a slow start to 2025, with GST 2.0 emerging as the main catalyst.

50 Mn To 100 Mn Indians Suffer From Long Covid

50 Mn To 100 Mn Indians Suffer From Long Covid

Rediff.com   2 Dec 2025

Even by conservative assumptions that 5 to 10 per cent of infected individuals develop long Covid, India today may be home to 50 to 100 million infected individuals -- many silently coping with breathlessness, fatigue, palpitations, brain fog, or unexplained clotting tendencies.

Seniors to Drive 25% of India's Pharma

Seniors to Drive 25% of India's Pharma

Rediff.com   21 Nov 2025

'Once the 60-plus population hits 20 to 30 per cent of the country, the demand for elderly-care treatments will surge -- cardiac, metabolic, neurological, and musculoskeletal medicines are going to dominate the market for the next several decades.'

Pune Firm Unveils Diabetes-Control Implant

Pune Firm Unveils Diabetes-Control Implant

Rediff.com   19 Nov 2025

This innovation works by stimulating our natural organs so that it can produce and maintain the insulin balance.

VinFast Outsells Tesla in Festival Season But BYD Is King

VinFast Outsells Tesla in Festival Season But BYD Is King

Rediff.com   10 Nov 2025

Vinfast sold 137 cars versus Tesla's 109 during the festive months of September and October, as BYD maintained a strong lead with over 1,100 cars sold, according to Fada data.

USFDA's new draft biosimilar rules to benefit Indian biotech cos

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Rediff.com   9 Nov 2025

The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.

Bajaj Auto posts highest ever quarterly revenue and PAT

Bajaj Auto posts highest ever quarterly revenue and PAT

Rediff.com   8 Nov 2025

Pune-based two-wheeler major Bajaj Auto posted its highest ever quarterly revenue and profit after tax (PAT) in Q2FY26. Even as consolidated revenues were up 18.8 per cent year-on-year (Y-o-Y) to Rs 15,734.7 crore, PAT zoomed 53.2 per cent to Rs 2,122 crore.

Where The Deadly Cough Syrup Was Made

Where The Deadly Cough Syrup Was Made

Rediff.com   18 Oct 2025

Sandwiched between a Hero MotoCorp showroom and a shop that hires out cooking utensils is a small, dingy building that's been locked up. The non-descript two-room building is a manufacturing unit of Sresan Pharmaceuticals, the pharma company made its Coldriff cough syrup that has allegedly killed 25 children in Madhya Pradesh.

Electric PV sales more than double in September; Tata Motors leads

Electric PV sales more than double in September; Tata Motors leads

Rediff.com   9 Oct 2025

Electric passenger vehicle (PV) retail sales jumped more than twofold in September with Tata Motors (TaMo) leading the pack having over 6,000 registrations and a 40 per cent market share.

Mercedes clocks record Navratri sale of 2,500 cars

Mercedes clocks record Navratri sale of 2,500 cars

Rediff.com   8 Oct 2025

'We expect this festival buying spirit to continue in October as well, with upcoming festivities including Dhanteras and Diwali, which traditionally witness spirited buying from customers.'